A study in the Archives of Dermatology finds minority patients are at greater risk for advanced disease when it's harder to cure.
Just 4.5 percent of white patients were diagnosed with the advanced form, compared to 8 percent of Hispanic patients and nearly 15 percent of African-American patients.